לינפארזה 50 מג ישראל - עברית - Ministry of Health

לינפארזה 50 מג

astra zeneca (israel) ltd - olaparib - קפסולה קשיחה - olaparib 50 mg - olaparib

קזודקס 150 מג ישראל - עברית - Ministry of Health

קזודקס 150 מג

astra zeneca (israel) ltd - bicalutamide - טבליה - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0) casodex 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

בודיקורט רספיולס 0.5 מ"ג/2 מ"ל ישראל - עברית - Ministry of Health

בודיקורט רספיולס 0.5 מ"ג/2 מ"ל

astra zeneca israel ltd - budesonide 0.5 mg / 2 ml - suspension for inhalation - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.

בודיקורט רספיולס 1 מ"ג/2 מ"ל ישראל - עברית - Ministry of Health

בודיקורט רספיולס 1 מ"ג/2 מ"ל

astra zeneca israel ltd - budesonide 1 mg / 2 ml - suspension for inhalation - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.

נזוקורט אקווה 32 מקגמנה ישראל - עברית - Ministry of Health

נזוקורט אקווה 32 מקגמנה

astra zeneca (israel) ltd - budesonide micronized - ספריי לאף - budesonide micronized 0.64 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.

נזוקורט אקווה 64 מקגמנה ישראל - עברית - Ministry of Health

נזוקורט אקווה 64 מקגמנה

astra zeneca (israel) ltd - budesonide micronized - ספריי לאף - budesonide micronized 1.28 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.

וימובו ישראל - עברית - Ministry of Health

וימובו

astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers.vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

וימובו ישראל - עברית - Ministry of Health

וימובו

astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers. vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

וימובו ישראל - עברית - Ministry of Health

וימובו

astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers. vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

קפרלסה 100 מ"ג ישראל - עברית - Ministry of Health

קפרלסה 100 מ"ג

astra zeneca israel ltd - vandetanib 100 mg - film coated tablets - vandetanib - caprelsa is indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (mtc) in patients with unresectable locally advanced or metastatic disease. for patients in whom rearranged during transfection (ret) mutation is not known or is negative, a possible lower benefit should be taken into account before individual treatment decision